Mitchell Anscher, M.D.
U.S. Food and Drug Administration
Dr. Anscher is a Medical Officer, on the Genitourinary Team in the Division of Oncology Products 1, in the Office of Hematology and Oncology Products, in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). Prior to joining the FDA, Dr. Anscher served as Professor and Genitourinary Section Chief in the Department of Radiation Oncology at the University of Texas, M.D. Anderson Cancer Center, Florence and Hyman Meyers Professor and Chair of the Department of Radiation Oncology at Virginia Commonwealth University; he also served as Professor and Clinical Director in the Department of Radiation Oncology at Duke University, where he launched the prostate cancer brachytherapy program, and co-founded the genitourinary multidisciplinary tumor board. Dr. Anscher received his bachelor’s degree from Stanford University and his MD degree from Virginia Commonwealth University School of Medicine. He completed his residency in Internal Medicine at St. Mary’s Hospital in Waterbury, CT and his residency in Radiation Oncology at Duke University Medical Center.
Dr. Anscher is board certified in both Internal Medicine and Radiation Oncology, his funded research interests included clinical trials in Genitourinary malignancies and molecular and translation research into normal tissue injury following cancer therapies. He has published over 300 research articles and reviews, book chapters, abstracts and 3 books. During his 32 years in academic medicine, Dr. Anscher has mentored numerous trainees ranging from high school students to post-doctoral fellows, residents and visiting scientists. He has lectured widely both in the U.S. and abroad and has served as visiting professor at numerous institutions. He is the recipient of the R. Wayne Rundles Award for Excellence in Cancer Research from Duke University, the Outstanding Alumnus Award from Virginia Commonwealth University School of Medicine and was named one of America’s Top Doctors for 20 consecutive years. Dr. Anscher has been awarded fellowships in the American College of Radiology, American Society for Radiation Oncology and the American College of Radiation Oncology. He has served on numerous national and international grant review committees, and on the Program Committees for the Annual Meetings of the Radiation Research Society and the American Society of Radiation Oncology for which he has chaired the Genitourinary Subcommittee.